Demant A/S (CPH:DEMANT)
233.00
+1.80 (0.78%)
At close: Jan 16, 2026
Demant Market Cap
Demant has a market cap or net worth of 49.25 billion as of January 16, 2026. Its market cap has decreased by -15.02% in one year.
Market Cap
49.25B
Enterprise Value
64.36B
Revenue
22.59B
Ranking
n/a
PE Ratio
18.49
Stock Price
233.00
Market Cap Chart
Since November 21, 1995, Demant's market cap has increased from 2.12B to 49.25B, an increase of 2,224.22%. That is a compound annual growth rate of 10.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 49.63B | 8.27% |
| Dec 30, 2025 | 45.84B | -20.30% |
| Dec 30, 2024 | 57.52B | -10.34% |
| Dec 29, 2023 | 64.15B | 51.17% |
| Dec 30, 2022 | 42.43B | -47.09% |
| Dec 30, 2021 | 80.20B | 39.08% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.62T |
| Genmab | 133.30B |
| Coloplast | 129.99B |
| ALK-Abelló | 49.28B |
| H. Lundbeck | 43.35B |
| Zealand Pharma | 28.69B |
| Ambu A/S | 24.40B |
| GN Store Nord | 16.98B |